戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ogram, mitral valve prolapse, arrhythmia, or restrictive lung disease.
2 ltrative process, abnormal gas exchange, and restrictive lung disease.
3  differed between underlying obstructive and restrictive lung disease.
4  in lung development and the pathogenesis of restrictive lung disease.
5 ath variability was reduced in patients with restrictive lung disease: 27 times for expiratory time,
6    The most common type of major sequela was restrictive lung disease (5.4% [2.5-10.2%]) .
7                 In conclusion, patients with restrictive lung disease adopt a tightly constrained bre
8 cant increases in interstitial thickening or restrictive lung disease among this population.
9 e chest wall and/or vertebrae that result in restrictive lung disease and compromised respiratory cap
10 veloped severe dyspnea and was found to have restrictive lung disease and evidence of alveolitis.
11 nificant, independent, protective factor for restrictive lung disease and FVC or DLCO values.
12 nobtrusively over 1 hour in 10 patients with restrictive lung disease and in 7 healthy subjects.
13  States and in severe cases can resolve with restrictive lung disease and pleural fibrosis.
14 ive pulmonary disease (COPD), one had severe restrictive lung disease, and one had a coagulopathy; th
15 ant contractures with limited eye movements, restrictive lung disease, and variable absence of crucia
16 in patients with CHD with renal dysfunction, restrictive lung disease, anemia, and cirrhosis.
17                                Patients with restrictive lung disease are typically dyspneic and have
18 ctional abnormalities, such as emphysema and restrictive lung diseases, are frequently observed in pa
19 oracic configuration, in addition to causing restrictive lung disease, can cause respiratory distress
20 ordingly, we hypothesized that patients with restrictive lung disease display decreased variability o
21 lts aged 18 to 80 years with obstructive and restrictive lung disease from a single large-volume tran
22 of HP before extensive pulmonary fibrosis or restrictive lung disease has occurred.
23 ed cognitive ability, poor pulmonary status, restrictive lung disease, history of frequent pneumonias
24 nge of pigmentation and an increased risk of restrictive lung disease in adults.
25 ion in this population has mainly focused on restrictive lung disease, in patients with severe CHD ph
26                          In adults with NMD, restrictive lung disease is in part caused by reduced ch
27 tandard global burden of disease categories (restrictive lung disease, obstructive lung disease, bron
28 ; odds ratio, 2.0; p =.032) and a history of restrictive lung disease (odds ratio, 3.6; p =.044).
29 ibrosis in 8 of 10 patients (1.2% of the 760 restrictive lung disease patients transplanted in the sa
30                           They suffered from restrictive lung disease requiring noninvasive mechanica
31                  These complications include restrictive lung disease, sleep abnormalities, plastic b
32 ology measures highlighted two phenotypes of restrictive lung disease that differed according to thei
33 hic pulmonary fibrosis (IPF), a progressive, restrictive lung disease that is refractory to glucocort
34 ncluded 30 050 patients with obstructive and restrictive lung disease with primary care encounters (m
35                 22q11.2DS is associated with restrictive lung disease, worse aerobic capacity, and in